KYMR - Kymera Therapeutics, Inc.

83.52
-2.590   -3.101%

Share volume: 1,044,442
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$86.11
-2.59
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 05-02-2024 08-07-2024 10-31-2024 02-27-2025 05-09-2025 11-04-2025 02-26-2026
Total revenue 10.287 M 25.650 M 3.741 M 7.394 M 22.100 M 2.764 M 2.871 M
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 10.287 M 25.650 M 3.741 M 7.394 M 22.100 M 2.764 M 2.871 M
    149.34% -85.42% 97.65% 198.89% -87.49% 3.87%  
Operating expenses 63.193 M 76.575 M 75.865 M 88.149 M 96.526 M 91.430 M 100.766 M
Selling general and admin 14.374 M 17.373 M 15.455 M 16.332 M 16.271 M 17.336 M 16.935 M
Research and development 48.819 M 59.202 M 60.410 M 71.817 M 80.255 M 74.094 M 83.831 M
Total expenses 68.118 M 76.575 M 75.865 M 88.149 M 96.526 M 95.285 M 100.766 M
    12.42% -0.93% 16.19% 9.50% -1.29% 5.75%  
Operating income -57.831 M -50.925 M -72.124 M -80.755 M -74.426 M -92.521 M -97.895 M
Ebit -48.557 M -42.062 M -62.487 M -70.752 M -65.581 M -82.175 M -86.981 M
Pretax income -48.557 M -42.062 M -62.487 M -70.752 M -65.581 M -82.175 M -86.981 M
    -13.38% 48.56% 13.23% -7.31% 25.30% 5.85%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -48.557 M -42.062 M -62.487 M -70.752 M -65.581 M -82.175 M -86.981 M
    13.38% -48.56% -13.23% 7.31% -25.30% -5.85%